Literature DB >> 25017010

Transneuronal propagation of mutant huntingtin contributes to non-cell autonomous pathology in neurons.

Eline Pecho-Vrieseling1, Claus Rieker1, Sascha Fuchs2, Dorothee Bleckmann2, Maria Soledad Esposito3, Paolo Botta4, Chris Goldstein2, Mario Bernhard2, Ivan Galimberti2, Matthias Müller2, Andreas Lüthi4, Silvia Arber3, Tewis Bouwmeester2, Herman van der Putten5, Francesco Paolo Di Giorgio2.   

Abstract

In Huntington's disease (HD), whether transneuronal spreading of mutant huntingtin (mHTT) occurs and its contribution to non-cell autonomous damage in brain networks is largely unknown. We found mHTT spreading in three different neural network models: human neurons integrated in the neural network of organotypic brain slices of HD mouse model, an ex vivo corticostriatal slice model and the corticostriatal pathway in vivo. Transneuronal propagation of mHTT was blocked by two different botulinum neurotoxins, each known for specifically inactivating a single critical component of the synaptic vesicle fusion machinery. Moreover, healthy human neurons in HD mouse model brain slices displayed non-cell autonomous changes in morphological integrity that were more pronounced when these neurons bore mHTT aggregates. Altogether, our findings suggest that transneuronal propagation of mHTT might be an important and underestimated contributor to the pathophysiology of HD.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25017010     DOI: 10.1038/nn.3761

Source DB:  PubMed          Journal:  Nat Neurosci        ISSN: 1097-6256            Impact factor:   24.884


  58 in total

Review 1.  Huntington's disease: progress and potential in the field.

Authors:  Edward C Stack; Robert J Ferrante
Journal:  Expert Opin Investig Drugs       Date:  2007-12       Impact factor: 6.206

2.  Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice.

Authors:  M A Hickey; A Kosmalska; J Enayati; R Cohen; S Zeitlin; M S Levine; M-F Chesselet
Journal:  Neuroscience       Date:  2008-08-27       Impact factor: 3.590

3.  Single-step detection of mutant huntingtin in animal and human tissues: a bioassay for Huntington's disease.

Authors:  Andreas Weiss; Dorothée Abramowski; Miriam Bibel; Ruth Bodner; Vanita Chopra; Marian DiFiglia; Jonathan Fox; Kimberly Kegel; Corinna Klein; Stephan Grueninger; Steven Hersch; David Housman; Etienne Régulier; H Diana Rosas; Muriel Stefani; Scott Zeitlin; Graeme Bilbe; Paolo Paganetti
Journal:  Anal Biochem       Date:  2009-08-06       Impact factor: 3.365

Review 4.  Huntington's disease and the striatal medium spiny neuron: cell-autonomous and non-cell-autonomous mechanisms of disease.

Authors:  Michelle E Ehrlich
Journal:  Neurotherapeutics       Date:  2012-04       Impact factor: 7.620

5.  Staining protocol for organotypic hippocampal slice cultures.

Authors:  Nadine Gogolla; Ivan Galimberti; Vincenzo DePaola; Pico Caroni
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

Review 6.  Huntington's disease: from molecular pathogenesis to clinical treatment.

Authors:  Christopher A Ross; Sarah J Tabrizi
Journal:  Lancet Neurol       Date:  2011-01       Impact factor: 44.182

7.  Abnormal association of mutant huntingtin with synaptic vesicles inhibits glutamate release.

Authors:  He Li; Travis Wyman; Zhao-Xue Yu; Shi-Hua Li; Xiao-Jiang Li
Journal:  Hum Mol Genet       Date:  2003-08-15       Impact factor: 6.150

8.  A modified RMCE-compatible Rosa26 locus for the expression of transgenes from exogenous promoters.

Authors:  Jan S Tchorz; Thomas Suply; Iwona Ksiazek; Claudio Giachino; Dimitri Cloëtta; Claus-Peter Danzer; Thierry Doll; Andrea Isken; Marianne Lemaistre; Verdon Taylor; Bernhard Bettler; Bernd Kinzel; Matthias Mueller
Journal:  PLoS One       Date:  2012-01-13       Impact factor: 3.240

9.  Trans-synaptic spread of tau pathology in vivo.

Authors:  Li Liu; Valerie Drouet; Jessica W Wu; Menno P Witter; Scott A Small; Catherine Clelland; Karen Duff
Journal:  PLoS One       Date:  2012-02-01       Impact factor: 3.240

10.  Atg4b-dependent autophagic flux alleviates Huntington's disease progression.

Authors:  Catia C Proenca; Natacha Stoehr; Mario Bernhard; Shanon Seger; Christel Genoud; Ana Roscic; Paolo Paganetti; Shanming Liu; Leon O Murphy; Rainer Kuhn; Tewis Bouwmeester; Ivan Galimberti
Journal:  PLoS One       Date:  2013-07-08       Impact factor: 3.240

View more
  78 in total

Review 1.  Induced Pluripotent Stem Cells in Huntington's Disease: Disease Modeling and the Potential for Cell-Based Therapy.

Authors:  Ling Liu; Jin-Sha Huang; Chao Han; Guo-Xin Zhang; Xiao-Yun Xu; Yan Shen; Jie Li; Hai-Yang Jiang; Zhi-Cheng Lin; Nian Xiong; Tao Wang
Journal:  Mol Neurobiol       Date:  2015-12-10       Impact factor: 5.590

Review 2.  The choreography of neuroinflammation in Huntington's disease.

Authors:  Andrea Crotti; Christopher K Glass
Journal:  Trends Immunol       Date:  2015-05-20       Impact factor: 16.687

Review 3.  Neurodegenerative diseases: expanding the prion concept.

Authors:  Lary C Walker; Mathias Jucker
Journal:  Annu Rev Neurosci       Date:  2015-03-30       Impact factor: 12.449

Review 4.  The Tiny Drosophila Melanogaster for the Biggest Answers in Huntington's Disease.

Authors:  Abraham Rosas-Arellano; Argel Estrada-Mondragón; Ricardo Piña; Carola A Mantellero; Maite A Castro
Journal:  Int J Mol Sci       Date:  2018-08-14       Impact factor: 5.923

5.  Something wicked this way comes: huntingtin.

Authors:  Albert R La Spada
Journal:  Nat Neurosci       Date:  2014-08       Impact factor: 24.884

6.  Engineered antibody therapies coming of age for aging brains.

Authors:  Anne Messer
Journal:  Mol Ther       Date:  2014-10       Impact factor: 11.454

7.  Potential Transfer of Polyglutamine and CAG-Repeat RNA in Extracellular Vesicles in Huntington's Disease: Background and Evaluation in Cell Culture.

Authors:  Xuan Zhang; Erik R Abels; Jasmina S Redzic; Julia Margulis; Steve Finkbeiner; Xandra O Breakefield
Journal:  Cell Mol Neurobiol       Date:  2016-03-07       Impact factor: 5.046

Review 8.  The biology of proteostasis in aging and disease.

Authors:  Johnathan Labbadia; Richard I Morimoto
Journal:  Annu Rev Biochem       Date:  2015-03-12       Impact factor: 23.643

Review 9.  Prion-Like Characteristics of Polyglutamine-Containing Proteins.

Authors:  Margaret M P Pearce; Ron R Kopito
Journal:  Cold Spring Harb Perspect Med       Date:  2018-02-01       Impact factor: 6.915

10.  Phagocytic glia are obligatory intermediates in transmission of mutant huntingtin aggregates across neuronal synapses.

Authors:  Kirby M Donnelly; Olivia R DeLorenzo; Aprem DA Zaya; Gabrielle E Pisano; Wint M Thu; Liqun Luo; Ron R Kopito; Margaret M Panning Pearce
Journal:  Elife       Date:  2020-05-28       Impact factor: 8.140

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.